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Abstract
Objective—Acute otitis externa (AOE) is a common but preventable ear condition. Clinical 
guidelines issued in 2006 recommended topical treatments for uncomplicated AOE, but systemic 
antimicrobials appear to be commonly prescribed. The objective of this analysis was to describe 
pre- and postguideline prescribing patterns by clinician specialty and antimicrobial type and assess 
trends over time.
Study Design—Retrospective longitudinal analysis of a large insurance database.
Setting—Outpatient departments in the United States.
Methods—Initial outpatient visits in 2004 to 2010 for AOE (excluding visits with complicating 
conditions) were extracted from an insurance database. Prescription drug claims were linked and 
categorized by clinician specialty and antimicrobial type.
Results—The analysis included 907,261 initial outpatient visits. Use of systemic antimicrobials 
declined by 4.9% (95% confidence interval [CI], 4.1%, 5.7%) from 36.5% of initial visits in 2004 
to 32.1% in 2010. Use of systemic antimicrobials varied by specialty. Systemic antimicrobials 
were prescribed in 47.1% of 2010 emergency department (ED) visits (−6.9% from 2004, 95% CI –
12.3, −1.5), 25.9% of otolaryngologist visits (−1.6%, 95% CI –5.6, 2.4), and 20.4% of pediatrician 
visits (−6.6%, 95% CI –8.8, –4.4). Penicillins were prescribed most frequently (42.3% of systemic 
prescriptions in 2010), followed by cephalosporins (19.8%), erythromycin/macrolides (17.4%), 
and quinolones (11.1%). Opioids were prescribed in 26.4% of ED visits and 9% of outpatient 
visits.
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Conclusions—Use of systemic antimicrobials declined over time, but one-third of 2010 visits 
resulted in systemic antimicrobials, despite exclusion of visits with complicating factors. Use of 
systemic antimicrobials varied by specialty. Further educational efforts and outreach to other 
specialties might be warranted.
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Acute otitis externa (AOE), the common but preventable inflammation of the outer ear 
known as “swimmer’s ear,”1,2 leads to approximately 2.4 million ambulatory and 
emergency department (ED) visits each year, taking up more than half a million hours of 
providers’ time annually.3 Prevention strategies focus on keeping the ears dry (ie, drying the 
ear after swimming, bathing, or showering using alcohol-based drops or a hair dryer), while 
the accessible nature of the externa ear canal suggests that AOE is well-suited to topical 
treatment.
Evidence-based clinical practice guidelines published in 2006 call for initial treatment of 
uncomplicated AOE with topical antimicrobial preparations, including preparations 
containing antibiotics, steroids, or low-pH antiseptics (eg, aluminum acetate).4,5 Systemic 
antimicrobial treatment has not shown additional benefits for uncomplicated AOE5 and is 
recommended only when complicating factors are present (eg, diabetes or conditions 
predisposing patients to wider infection). Topical treatments are formulated for activity 
against Pseudomonas aeruginosa and Staphylococcus aureus (the most common organisms 
implicated in AOE) and, unlike systemic treatments, can deliver doses of antimicrobial 
ingredients well above the minimum inhibitory concentration of resistant organisms.6
Analyses conducted in the United States prior to release of the current clinical guidelines 
suggested high rates of systemic antimicrobial use, with systemic antimicrobials prescribed 
in one-quarter to one-half of visits.7,8 A comparison of systemic antimicrobial use before 
and after guideline publication found little change in prescribing patterns, suggesting low 
levels of adoption and adherence to the guidelines by clinicians.9 Description of pre- and 
postguideline prescribing patterns by clinician specialty or antimicrobial type could identify 
opportunities to increase awareness of the evidence-based guidelines.
Methods
Outpatient visits (ambulatory care and ED visits) for AOE and prescriptions were assessed 
using insurance claims from 2004 to 2010 (the most recent year for which data were 
available) from the Marketscan Commercial Claims and Encounters database. The database 
contains deidentified, preexisting insurance billing records. Because no interaction or 
intervention with human subjects occurred and no personally identifiable information was 
used, collected, or transmitted in the course of this analysis of previously collected data, the 
analysis was not considered human subjects research (as defined in 45 CFR part 46) subject 
to review by the institutional review board. The database contains a large convenience 
sample of commercially insured persons. There was some variation in participating 
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employers and health plans over the study period. Sample size increased each year, from 13 
million covered lives in 2004 to 45 million covered lives in 2010.
Initial outpatient visits for AOE (ICD-9-CM codes 380.10 and 380.12) with a prescription 
filled within 1 day and without a concurrent diagnosis of otitis media (OM); diabetes; 
cellulitis, periauriculitis, or lymphadenitis; immune compromise (as defined in the list of 
immunocompromising conditions in the Prevention Quality Indicators Technical 
Specifications published by the Agency for Health Research and Quality10); or malignant 
otitis externa were included. Initial visits were defined as AOE visits for patients who did 
not have an AOE visit within the past 365 days. There were 1,155,169 AOE visits with a 
prescription filled within 1 day. Of those visits, 140,384 visits (12.2%) were follow-up 
visits, 113,553 (9.8%) had a concurrent diagnosis of otitis media, 5,245 (0.5%) had a 
concurrent diagnosis of cellulitis or other evidence of wider infection, 4919 (0.4%) had a 
concurrent diagnosis of diabetes, 174 (0.0%) had a concurrent immunocompromising 
condition, and 19 (0.0%) had a concurrent diagnosis of malignant otitis externa. A total of 
247,908 visits (21.5%) were excluded because they had 1 or more of these exclusionary 
factors.
Prescription drug claims were categorized by clinician specialty and antimicrobial type. To 
assess trends in prescribing patterns over time for each specialty, Poisson regression was 
used. Poisson regression is used to model count data and can be adapted to model 
proportions or rates through the use of an offset (ie, modeling counts per unit of a 
denominator variable, such as person-time, instead of modeling count data alone). PROC 
GENMOD and PROC NLMIXED (SAS version 9.2, Cary, North Carolina) were used, and 
data were modeled using the number of visits resulting in a prescription of the medication 
type of interest as the dependent variable, the year as the independent variable, and the total 
number of visits as the offset. The proportion of visits resulting in a prescription of the 
medication type of interest and Wald 95% confidence intervals (CIs) for the proportion were 
calculated using estimate statements. CIs for the total change in percentage of visits 
resulting in a prescription of the medication type of interest from 2004 to 2010 were 
calculated as described in SAS documentation for calculation of rate differences and CIs 
using PROC NLMIXED.11 The types of systemic antimicrobials prescribed by each clinical 
specialty in 2010 (the most recent year for which complete data were available) were 
assessed using univariate Poisson regression, with the number of visits resulting in a 
prescription of the systemic antimicrobial drug of interest as the dependent variable, the 
specialty as the independent variable, and the total number of visits resulting in a systemic 
antimicrobial prescription as the offset.
Results
The analysis included 907,261 initial outpatient visits. Most visits were to ambulatory care, 
while 7.5% were ED visits. For outpatient records, up to 4 ICD-9-CM codes can be reported 
for each visit. The most frequently co-occurring diagnostic codes were otalgia (2.6%) and 
impacted cerumen (2.4%).
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Overall, use of systemic antimicrobials declined from 36.5% of initial visits in 2004 to 
32.1% in 2010 (−4.4%, 95% CI −5.0, −3.8; Table 1, Figure 1). Use of systemic 
antimicrobials declined significantly in each specialty studied, with the exception of 
otolaryngologists (27.5% of visits in 2004, 25.9% of visits in 2010 [−1.6%, 95% CI −5.6, 
2.4]). The largest decline occurred among ED physicians (53.9% of visits in 2004 to 47.1% 
of visits in 2010 [−6.9%, 95% CI −12.3, −1.5]). Visits in which only topical antimicrobials 
were prescribed showed a concurrent rise, from 60.4% in 2004 to 65.3% in 2010 (4.9%, 
95% CI 4.1, 5.7). Pediatricians (78.3% of visits in 2010) and otolaryngologists (65.5% of 
visits in 2010) were most likely to prescribe topical antimicrobial treatments only.
Prescriptions for opioid pain relievers declined significantly from 2004 (9.0% of outpatient 
visits and 35.4% of ED visits) to 2010 (7.3% of outpatient visits [−1.7%, 95% CI −2.0, −1.4) 
and 26.4% of ED visits (−9.1%, 95% CI −13.4, −4.7). Only 1.9% of 2010 outpatient visits 
resulted in a non-steroidal anti-inflammatory drug (NSAID) prescription, a proportion that 
did not significantly increase from 2004 (0.2% increase, 95% CI 0.0, 0.3).
When systemic antimicrobials were prescribed, penicillins were prescribed most frequently 
(42.3% in 2010), followed by cephalosporins (19.8%), erythromycin/macrolides (17.4%), 
and quinolones (11.1%; Table 2). Overall, prescriptions for penicillins (−3.6%, 95% CI 
−4.7, −2.4) and cephalosporins (−4.0%, 95% CI −4.8, −3.1) decreased, while prescriptions 
for erythromycin/macrolides (2.2%, 95% CI 1.5, 2.9) and sulfonamides (4.6%, 95% CI 4.2, 
4.9) increased.
In 2010, the most recent year for which complete data were available, otolaryngologists 
prescribed a greater proportion of quinolones when systemic antimicrobials were prescribed 
(32.2% of visits, 95% CI 30.3, 34.2) and a smaller proportion of penicillins (26.6%, 95% CI 
24.9, 28.5) than other specialties (Table 3). Pediatricians prescribed penicillins 53.8% of the 
time (95% CI 52.3, 55.2) and quinolones in 1.1% of visits (95% CI 0.9, 1.3).
Discussion
More than 900,000 pre- and postguideline outpatient visits for AOE were included in this 
detailed analysis of prescribing patterns. The frequency of systemic antimicrobial 
prescriptions showed a decline from 2004 to 2010 within each clinical specialty studied. 
However, declines were modest (−4.4% overall [95% CI −5.0, −3.8], from 36.5% to 32.1%), 
and one-third of visits in 2010 resulted in prescriptions for systemic antimicrobials, despite 
exclusion of repeat visits and visits with complicating factors. The use of systemic 
antimicrobials varied by specialty. Otolaryngologists and pediatricians had the lowest rate of 
systemic antimicrobial use overall, while ED physicians were most likely to prescribe 
systemic antimicrobials.
An estimated 2.4 million outpatient visits for AOE without a concurrent diagnosis of OM 
occurred in 2007 (the most recent estimate of AOE prevalence available), at an average cost 
of $200 per visit, including visit and prescription drug costs.3,12 Assuming that the 
prevalence of AOE has not changed and the proportion of systemic antimicrobial 
prescriptions for all AOE visits is similar to the proportion observed in this analysis, 
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systemic antimicrobials could be prescribed for AOE more than 770,000 times each year 
(32.1% of 2.4 million). While the true percentage of visits for AOE involving complicating 
factors is unknown, increased use of topical preparations for uncomplicated AOE could 
prevent unnecessary use of systemic antimicrobials. Future work could explore the potential 
cost savings produced by using topical preparations alone for uncomplicated AOE.
Topical preparations are recommended for AOE in the absence of complicating factors: they 
are effective against P aeruginosa and S aureus and provide concentrated doses of 
antimicrobials effective even against resistant organisms.6 Penicillins (primarily 
amoxicillin) were prescribed in 42.3% of 2010 visits with a systemic antimicrobial 
prescription (a decline of 3.6% [95% CI −4.7, −2.4] from 2004). Amoxicillin is 
recommended for OM but is unlikely to be effective against P aeruginosa. OM and AOE 
can be difficult to distinguish, particularly when the tympanic membrane is not well 
visualized, which could explain the high percentage of penicillin prescriptions (53.8% of 
systemic antimicrobial prescriptions) by pediatricians despite the exclusion of visits with 
concurrent OM. However, the physiologic changes in the Eustachian tubes that occur with 
age suggest that the relative contribution of AOE to all ear infections could increase with 
age. More than half of AOE visits occurred in patients older than 14 years of,3,13 while the 
majority of acute OM has been estimated to occur in children younger than 5 years.14 
Because pathogens and effective therapies differ for OM and AOE, increased consideration 
of AOE in adults and older children could be warranted.
One-quarter of 2010 ED visits resulted in a prescription for an opioid pain reliever. AOE can 
be exquisitely painful; pain assessment and management, including opioid use when 
necessary, is included in the guidelines.4 While ED clinicians had a higher proportion of 
prescriptions for opioids, it is likely that AOE patients visiting the ED were motivated to 
seek immediate treatment because of higher pain levels. However, because opioids have the 
potential for abuse and are an emerging cause of unintentional deaths,15 improved AOE 
prevention represents an opportunity for reducing opioid prescriptions.
This analysis is subject to multiple limitations. First, billing records, not medical records, 
were used. Systemic antimicrobial prescriptions could be appropriate, given other diagnoses 
not reflected in the billing record, and prescription drugs costing less than a copayment 
might be absent from the record. The analysis also relied on ICD-9 coding contained in the 
billing records. ICD-9 codes may be entered retrospectively by nonphysicians and may not 
fully reflect diagnoses recorded in the medical record.16,17 Second, the Marketscan database 
is a large convenience sample of insurers and contributors to the database changed over the 
study period. Because of this, no conclusions about trends in the overall prevalence of AOE 
or changes in the proportion of AOE visits treated by each specialty can be made. Third, 
although the guidelines call for pain assessment at each visit, this analysis was able to 
evaluate only prescriptions for pain relievers. We were unable to evaluate the actual rate of 
assessment of pain. In addition, we were unable to assess nonprescription treatments; thus, 
the prescription NSAID estimates are likely an underestimate of the true rate of NSAID use. 
Finally, this analysis included commercially insured patients. Treatment and prescribing 
patterns could differ for the uninsured or for patients with other insurance sources.
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Improved implementation of clinical guidance could reduce the use of systemic 
antimicrobials when topical treatments are indicated. Use of systemic antimicrobials varied 
by specialty in this analysis, suggesting that guideline education efforts could be tailored to 
each clinician specialty. For example, AOE information was added to the American 
Academy of Pediatrics’ Red Book in 2012.18 Increased emphasis on patient education could 
also help prevent AOE. The Centers for Disease Control and Prevention has also made 
information and prevention materials for patients available.19–22 Greater adherence to the 
evidence-based clinical practice guidelines could reduce antimicrobial use, opioid use, and 
health care spending for a common, preventable disease.
Acknowledgments
The authors thank Lauri Hicks and Julia Gargano for helpful suggestions and thoughtful review of this manuscript.
Funding source: None.
References
1. Sander R. Otitis externa: a practical guide to treatment and prevention. Am Fam Physician. 2001; 
63:927–936. [PubMed: 11261868] 
2. Kaushik V, Malik T, Saeed SR. Interventions for acute otitis externa. Cochrane Database Syst Rev. 
2010; 1 CD004740. 
3. Centers for Disease Control and Prevention. Estimated burden of acute otitis externa—United 
States, 2003–2007. MMWR Morb Mortal Wkly Rep. 2011; 60:605–609. [PubMed: 21597452] 
4. Rosenfeld RM, Brown L, Cannon CR, et al. Clinical practice guideline: acute otitis externa. 
Otolaryngol Head Neck Surg. 2006; 134:S4–S23. [PubMed: 16638473] 
5. Hajioff D, Mackeith S. Otitis externa. Clin Evid (Online). 2010:510–532.
6. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope. 2002; 112:1166–
1177. [PubMed: 12169893] 
7. McCoy SI, Zell ER, Besser RE. Antimicrobial prescribing for otitis externa in children. Pediatr 
Infect Dis J. 2004; 23:181–183. [PubMed: 14872192] 
8. Halpern MT, Palmer CS, Seidlin M. Treatment patterns for otitis externa. J Am Board Fam Pract. 
1999; 1:1–7. [PubMed: 10050637] 
9. Bhattacharyya N, Kepnes LJ. Initial impact of the acute otitis externa clinical practice guideline on 
clinical care. Otolaryngol Head Neck Surg. 2011; 145:414–417. [PubMed: 21531870] 
10. Agency for Healthcare and Research Quality. Prevention Quality Indicators Technical 
Specifications. Rockville, MD: AHRQ; 2011. 
11. SAS Institute. Usage Note 37344: how can I estimate rate differences using a poisson model and 
get a confidence interval? 2009 Oct. http://support.sas.com/kb/37/344.html. 
12. Collier SA, Stockman LJ, Hicks LA, et al. Direct healthcare costs of selected diseases primarily or 
partially transmitted by water. Epidemiol Infect. 2012; 11:1–11.
13. Rowlands S, Devalia H, Smith C, et al. Otitis externa in UK general practice: a survey using the 
UK General Practice Research Database. Br J Gen Pract. 2001; 51:533–538. [PubMed: 11462312] 
14. Monasta L, Ronfani L, Marchetti F, et al. Burden of disease caused by otitis media: systematic 
review and global estimates. PLoS One. 2012; 7:e36226. [PubMed: 22558393] 
15. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain 
relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011:1487–1492. 
[PubMed: 22048730] 
16. Jones G, Taright N, Boelle PY, et al. Accuracy of ICD-10 codes for surveillance of Clostridium 
difficile infections, France. Emerg Infect Dis. 2012; 18:979–981. [PubMed: 22607707] 
17. Campbell SE, Campbell MK, Grimshaw JM, et al. A systematic review of discharge coding 
accuracy. J Public Health Med. 2001; 23:205–211. [PubMed: 11585193] 
Collier et al. Page 6













18. American Academy of Pediatrics. Prevention of illnesses associated with recreational water use. 
In: Pickering, LK., editor. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th 
ed.. Elk Grove Village, IL: American Academy of Pediatrics; 2012. p. 212-213.
19. Centers for Disease Control and Prevention. [Accessed March 7, 2012] Swimmer’s ear: 
recreational water illness (RWI). http://www.cdc.gov/healthywater/swimming/rwi/illnesses/
swimmers-ear.html.
20. Centers for Disease Control and Prevention. [Accessed March 7, 2012] Facts about swimmer’s ear. 
http://www.cdc.gov/healthywater/pdf/swimming/resources/pseudomonas-
factsheet_swimmers_ear.pdf.
21. Centers for Disease Control and Prevention. [Accessed March 7, 2012] Swimmer’s ear prevention 
guidelines. http://www.cdc.gov/healthywater/swimming/rwi/illnesses/swimmers-ear-prevention-
guidelines.html.
22. Centers for Disease Control and Prevention. [Accessed March 7, 2012] Datos sobre la “foliculitis 
de la bañera” y el “oído de nadador.”. http://www.cdc.gov/healthywater/pdf/swimming/resources/
pseudomonas-factsheet-esp.pdf.
Collier et al. Page 7














Prescribing patterns for systemic antimicrobials by clinician specialty, Marketscan 
Commercial Claims and Encounters database, United States, 2004 to 2010. Error bars 
indicate 95% confidence intervals for the percentage of visits resulting in a systemic 
antibiotic prescription, calculated using Poisson regression.
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